Abdullah, Siti Nurliyana http://orcid.org/0000-0001-7230-4618
Sanderson, Gordon F.
Husni, Mohd Aziz http://orcid.org/0000-0001-9949-364X
Maddess, Ted http://orcid.org/0000-0003-4591-3658
Funding for this research was provided by:
Australian Research Council (CE0561903)
Article History
Received: 19 June 2019
Accepted: 16 January 2020
First Online: 8 February 2020
Compliance with ethical standards
:
: Some readers will know that Maddess held the patents for the FDT/Matrix perimeters; however, those patents lapsed in 2015 and Maddess retains no interest in those Carl Zeiss products. Indeed, the R9 method of the paper might be seen as a competitor of FDT. Maddess has a small holding in and is on the advisory board of, EyeCo Pty Ltd, which is developing treatments for retina oedema and dry macular degeneration. He could also earn royalty income from patents assigned to Konan Medical USA Inc for a pupillography based perimetry system, but which has no features like R9 or FDT. R9 could be seen as a competitor to that potential product. Author SNA declares that she has no conflict of interest. Author GFS is deceased. Author MAH declares that he has no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of New South Wales and the University of Otago; and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of New South Wales and the University of Otago; and with the 1964 Helsinki declaration and its later amendments.
: No animals were involved in this study.
: Informed consent was obtained from all individual participants included in the study.